Cytodyn Inc (CYDY)

[DonDonDonDon]

This article talks a bit about it. The $150,000 injection must have come from a different interview.

https://www.bioprocessonline.com/doc/the-perilous-development-of-a-potential-biologic-blockbuster-0001

CytoDyn, the maker of leronlimab, was resurrected from the ashes in 2008 by an immigrant teacher with a PhD in mechanical engineering named Nader Pourhassan.

At the time, Pourhassan had been teaching mechanical engineering at the Center For Advanced Learning, a charter school in Gresham, OR while nurturing a few ancillary business partnerships. One of his partners, a 72-year-old named William, was holding 750,000 shares of a company called CytoDyn, which was then trading at a nickel. William, half desperate to unload his stake in the failing company, urged Pourhassan to meet CytoDyn’s CEO and help him turn things around. Pourhassan bristled. “I didn’t even know what biotechnology meant,” he tells me. “I wasn’t about to get involved.”

Pourhassan’s wife changed that paradigm, as spouses often do. She was weary of his frequent trips to China to nurture his business interests. She was convinced the CytoDyn project brought with it an opportunity to do something altruistic, to change peoples’ lives. “If it fails,” she reasoned, “we can always teach.” Her support sealed the deal. William helped Pourhassan sell off their business interests, and he went all-in on CytoDyn. Pourhassan joined the brink-of-bankruptcy organization as COO and was charged with its turnaround. For a year, he took no salary. His wife funded his travel, most of which was to raise enough funds to keep the company in the game.